精密医療ソフトウェアの市場規模・シェア・成長分析 (提供方法別、用途別、エンドユーザー別、地域別)：産業予測 (2024～2031年)

世界の精密医療ソフトウェアの市場規模は、2022年に13億1,000万米ドルと評価され、2023年の14億8,000万米ドルから2031年には38億1,000万米ドルに成長し、予測期間 (2024-2031年) のCAGRは12.6%で成長する見通しです。

世界の精密医療ソフトウェア市場は、技術の進歩と個別化された医療ソリューションへの需要の高まりに後押しされ、急速に進化しています。このソフトウェアは、医療提供者が患者の膨大なデータを分析し、遺伝・環境・ライフスタイルの変化を考慮してカスタマイズされた治療計画を可能にします。市場拡大の主な促進要因としては、慢性疾患の罹患率の上昇、ゲノミクスとプロテオミクスの進歩、電子カルテの普及拡大、政府の支援政策などが挙げられます。さらに、人工知能と機械学習アルゴリズムの組み込みは、精密医療ソフトウェアの機能を強化し、近い将来の市場成長をさらに促進する態勢を整えています。全体的な動向は、患者の転帰を最適化する、オーダーメイドの医療アプローチへの転換を強調しています。

目次

イントロダクション

• 分析目的
• 市場範囲
• 定義

分析手法

• 情報調達
• 二次・一次データの手法
• 市場規模予測
• 市場の想定と制約

エグゼクティブサマリー

• 市場の概要と展望
• 需給動向の分析
• セグメント別の機会分析

市場力学と展望

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーター分析と影響
  • 競争企業間の敵対関係
  • 代替品の脅威
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 供給企業の交渉力

市場の主な考察

• 主な成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場魅力度指数 (2023年)
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 技術進歩
• 規制情勢
• 特許分析
• ケーススタディ

世界の精密医療ソフトウェアの市場規模・CAGR：提供方法別 (2024～2031年)

• 市場概要
• Web・クラウドベース
• オンプレミス

世界の精密医療ソフトウェアの市場規模・CAGR：用途別 (2024～2031年)

• 市場概要
• 腫瘍学
• 薬理ゲノム学 (ファーマコゲノミクス)
• 希少疾患

世界の精密医療ソフトウェアの市場規模・CAGR：エンドユーザー別 (2024～2031年)

• 市場概要
• 医療提供者
• 研究センター・学術機関
• 製薬・バイオテクノロジー企業

世界の精密医療ソフトウェアの市場規模・CAGR (2024～2031年)

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • スペイン
  • フランス
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング (2023年)
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析 (2023年)
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較 (2021-2023)

主要企業プロファイル

• IBM Watson Health
• Oracle Corporation
• SAP SE
• SAS Institute Inc.
• Microsoft Corporation
• Flatiron Health, Inc.
• Syapse, Inc.
• Fabric Genomics, Inc.
• N-of-One, Inc.
• Gene42, Inc.
• PierianDx
• LifeOmic
• Tempus Labs, Inc.
• 2bPrecise LLC
• Human Longevity, Inc.
• GNS Healthcare
• Seven Bridges Genomics
• WuXi NextCODE
• Foundation Medicine, Inc.
• Strand Life Sciences

結論と推奨事項

Global Precision Medicine Software Market size was valued at USD 1.31 billion in 2022 and is poised to grow from USD 1.48 billion in 2023 to USD 3.81 billion by 2031, growing at a CAGR of 12.6% during the forecast period (2024-2031).

The global precision medicine software market is rapidly evolving, fueled by technological advancements and a growing demand for personalized healthcare solutions. This software empowers healthcare providers to analyze extensive patient data, enabling customized treatment plans that account for genetic, environmental, and lifestyle variations. Key drivers of market expansion include the rising incidence of chronic diseases, advancements in genomics and proteomics, a growing adoption of electronic health records, and supportive government policies. Additionally, the incorporation of artificial intelligence and machine learning algorithms is poised to enhance the capabilities of precision medicine software, further propelling market growth in the near future. The overall trend underscores a transformative shift towards tailored healthcare approaches, optimizing patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Precision Medicine Software market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Precision Medicine Software Market Segmental Analysis

Global Precision Medicine Software Market is segmented by delivery mode, application, end user and region. Based on delivery mode, the market is segmented into web & cloud-based and on-premises. Based on application, the market is segmented into oncology, pharmacogenomics and rare diseases. Based on end user, the market is segmented into healthcare providers, research centers and academic institutes and pharmaceutical and biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Precision Medicine Software Market

A significant driver of the global precision medicine software market is the rising demand for personalized healthcare solutions. As precision medicine focuses on delivering customized treatments tailored to an individual's unique genetic profile, lifestyle, and environmental influences, the need for corresponding software has surged. Technological advancements in genomic sequencing and big data analytics have made it easier to incorporate precision medicine into healthcare practices. This software allows providers to sift through extensive patient data, including genetic and medical histories, along with real-time monitoring, enabling more personalized treatment decisions. Growing awareness among patients and healthcare professionals about precision medicine's benefits continues to amplify the demand for supporting software solutions.

Restraints in the Global Precision Medicine Software Market

The global precision medicine software market faces significant restraints primarily due to the complexity and high costs involved in implementation and integration. This field necessitates the handling of vast amounts of genomic and clinical data, which requires sophisticated software systems capable of accurate analysis. However, healthcare organizations often encounter challenges, including interoperability issues and data privacy concerns, which complicate the integration process. Moreover, the extensive training required for healthcare professionals adds another layer of difficulty. High acquisition, maintenance, and upgrading costs further deter smaller healthcare institutions or those in resource-limited areas, hindering their capacity to adopt these advanced medical technologies.

Market Trends of the Global Precision Medicine Software Market

The global precision medicine software market is currently experiencing transformative trends that are reshaping healthcare delivery. A notable trend is the rising incorporation of artificial intelligence (AI) and machine learning (ML) technologies, which enhance diagnostic accuracy and facilitate the development of tailored treatment plans, ultimately leading to improved patient outcomes. Additionally, the increased embrace of cloud-based platforms is driving the secure, efficient storage and analysis of vast genomic and clinical datasets, further streamlining workflows. Moreover, a strong emphasis on interoperability and data standardization is fostering better integration among disparate healthcare systems, promoting collaboration among providers. Collectively, these trends are accelerating the adoption of precision medicine software, positioning it as a cornerstone of modern healthcare solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Case Studies

Global Precision Medicine Software Market Size by Delivery Mode & CAGR (2024-2031)

• Market Overview
• Web & Cloud-Based
• On-Premises

Global Precision Medicine Software Market Size by Application & CAGR (2024-2031)

• Market Overview
• Oncology
• Pharmacogenomics
• Rare Diseases

Global Precision Medicine Software Market Size by End User & CAGR (2024-2031)

• Market Overview
• Healthcare Providers
• Research Centers and Academic Institutes
• Pharmaceutical and Biotechnology Companies

Global Precision Medicine Software Market Size & CAGR (2024-2031)

• North America (Delivery Mode, Application, End User)
  • US
  • Canada
• Europe (Delivery Mode, Application, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Delivery Mode, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Delivery Mode, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Delivery Mode, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• IBM Watson Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oracle Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SAP SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SAS Institute Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microsoft Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Flatiron Health, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syapse, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fabric Genomics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• N-of-One, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gene42, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PierianDx
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeOmic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tempus Labs, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 2bPrecise LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Human Longevity, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GNS Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seven Bridges Genomics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi NextCODE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Foundation Medicine, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Strand Life Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation